Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

Clinical Outcomes of Double-dose Aflibercept Treatment for Refractory Wet Age-related Macular Degeneration: Sung Hyun Jo, Han Jo Kwon, Sung Who Park, Ik Soo Byon; J Korean Ophthalmol Soc. 2024;65(8):500-507. Published online August 14, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.8.500; Full text PubReader ePub PDF

Initial Factors Associated with Resistance to Intravitreal Aflibercept Injection in Polypoidal Choroidal Vasculopathy: Dayoung Moon, Minsub Lee, Hyewon Chung, Hyungwoo Lee; J Korean Ophthalmol Soc. 2024;65(7):425-434. Published online July 15, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.7.425; Full text PubReader ePub PDF Supplementary Material

Clinical Outcomes of Topical Bromfenac Combined with Intravitreal Aflibercept Injection for Exudative Age-related Macular Degeneration: Mi Sun Kwon, Jin Young Kim, Yu Min Kim et al.; J Korean Ophthalmol Soc. 2024;65(1):27-34. Published online January 15, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.1.27
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Efficacy of Injection Interval Shortening in Neovascular Age-related Macular Degeneration with Limited Response to Bimonthly Aflibercept: Min Chul Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2023;64(8):700-708. Published online August 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.8.700
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Course of Neovascular Age-related Macular Degeneration that Showed Limited Response to Both Ranibizumab and Aflibercept: Jeong Seop Yun, Chul Gu Kim, Jong Woo Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2023;64(4):313-322. Published online April 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.4.313; Full text PubReader ePub PDF

Haller Layer Thickness after Intravitreal Aflibercept Injection in Diabetic Macular Edema: 1 Month Change: Su Min Sung, Kyoo Won Lee, Hyun Gu Kang; J Korean Ophthalmol Soc. 2022;63(12):973-983. Published online December 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.12.973; Full text PubReader ePub PDF

Case Reports

A Case of Nonarteritic Anterior Ischemic Optic Neuropathy after Intravitreal Aflibercept Injection: Sungjun Joo, Joo Yeon Lee, Sung Uk Baek; J Korean Ophthalmol Soc. 2022;63(10):888-893. Published online October 14, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.10.888; Full text PubReader ePub PDF

Original Articles

Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept: Daeun Shin, Jae Hui Kim; J Korean Ophthalmol Soc. 2022;63(6):526-534. Published online June 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.6.526
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Association between Vortex Vein Engorgement and Treatment Outcomes of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Areum Jeong, Min Sagong; J Korean Ophthalmol Soc. 2021;62(10):1370-1380. Published online October 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.10.1370; Full text PubReader ePub PDF

Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration: Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(9):1218-1226. Published online September 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.9.1218
Web of Science 3 Crossref 3; Full text PubReader ePub PDF

Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration: Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(8):1076-1083. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1076
Web of Science 3 Crossref 5; Full text PubReader ePub PDF

Comparison of Intravitreal Bevacizumab and Aflibercept Injections for Central Serous Chorioretinopathy: Min Soo Park, Seung Joon Lee; J Korean Ophthalmol Soc. 2021;62(7):957-962. Published online July 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.7.957
Crossref 1; Full text PubReader ePub PDF

Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema.: Jangmi Yang, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(7):667-675. Published online July 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.7.667
Web of Science 3 Crossref 5; PDF

Use of Anti-vascular Endothelial Growth Factors for Diabetic Retnopathy: National Health Insurance Claims Data.: Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(7):661-666. Published online July 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.7.661
Web of Science 2 Crossref 9; PDF

Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept.: Tae Kyu Moon, Jun Young Ha, Mi Sun Sung, Sang Woo Park; J Korean Ophthalmol Soc. 2019;60(4):362-368. Published online April 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.4.362; PDF

Volume 67, No. 1

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

2,410	Risk Factors for Choroidal Detachment and Flat Anterior Chamber Following Ahmed Valve Implantation
5,001	Self-assessment of Visual Acuity Using a Smartphone Application
2,996	Genetic Characteristics of 63 Patients with Non-syndromic Retinitis Pigmentosa at a Single Korean Institution
3,342	Accuracy of Intraocular Lens Power Prediction Using 9 Formula
2,497	Comparison of Long-term Outcomes of Scleral-fixated IOL: Sutured vs. Suture-less Fixation

Cited By 3	A Case of Retinal Vasculitis, Uveitis in Myelin Oligodendrocyte Glycoprotein Antibody Associated Optic Neuritis
Cited By 3	The Effect of Topical Rebamipide 2% in Managing Dry Eye Following Cataract Surgery
Cited By 2	Comparison of Clinical Outcomes Among Sutured, Sutureless Scleral Fixation, and Retropupillary Fixation of Intraocular Lens
Cited By 1	Accuracy of Intraocular Lens Power Prediction Using 9 Formula
Cited By 1	Clinical Outcomes of Topical Bromfenac Combined with Intravitreal Aflibercept Injection for Exudative Age-related Macular Degeneration

Editorial Office: #1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603 Fax: +82-2-2277-5194 E-mail: kos@ijpnc.com

Copyright © 2026 by Korean Ophthalmological Society.

prev

next